Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups

Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin anticoagulation in non-valvular atrial fibrillation (NVAF). Methods. MEDLINE and CENTRAL, regulatory agencies websites, clinical trials registers and conference proceedin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gómez-Outes, Antonio, Terleira-Fernández, Ana Isabel, Calvo-Rojas, Gonzalo, Suárez-Gea, M. Luisa, Vargas-Castrillón, Emilio
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2013
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3885278/
https://ncbi.nlm.nih.gov/pubmed/24455237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/640723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados